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Background
Associations between HTLV-1 and pulmonary disease
have been reported but causality and risk have not been
confirmed. Pulmonary function tests have been routinely
offered to new patients attending the UK HTLV service
whilst a retrospective case review has been conducted to
determine the prevalence of diagnosed bronchiectasis.
Method
The cohort was categorised into HTLV-1 symptomatic
patients (SPs) (ATLL, HAM/TSP, polymyositis and
strongyloidiasis) and asymptomatic carriers (ACs). Com-
puterised tomographic (CT) imaging performed was
reviewed. In 60 patients disease state was correlated with
pulmonary function and HTLV-1 proviral load (VL).
Results
8/249 ACs and 27/164 SPs had a CT, with productive
cough +/- recurrent chest infections the predominant
indication. Bronchiectasis was diagnosed in one AC
(1/249) and 10 SPs (1 polymyositis, 1 ATLL, 8 HAM/
TSP) (10/164, OR 16.10; p=0.0084). In univariate analy-
sis increased rates of bronchiectasis were seen in HAM/
TSP patients compared with all other categories (OR
14.1 p<0.0001) and non-African/Afro-Caribbean ethni-
city subjects (OR 4.2; p=0.019) whilst age was signifi-
cantly associated with bronchiectasis (p=0.002). PEFR
(4.96 l/s vs. 6.77 l/s; p=0.0003), FEV1 (2.22 vs. 2.57;
p=0.06) and KCO (1.35 s-1 vs. 1.59 s-1; p=0.0029) were
all lower in SPs (n-27) compared with ACs (n-33) with
a negative correlation between VL and PEFR (rr-0.25).
Conclusion
Bronchiectasis was common in the cohort and therefore
HTLV serology should be considered in patients with
bronchiectasis. Patients with non-pulmonary HTLV-1-
associated disease are more likely to have an additional
diagnosis of bronchiectasis and obstructive lung disease
pattern than ACs suggesting an inflammatory aetiology.
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